2. Signaling Pathways
  3. Protein Tyrosine Kinase/RTK
  4. VEGFR
  5. VEGFR Isoform
  6. VEGFR Antagonist

VEGFR Antagonist

VEGFR Antagonist (1):

Cat. No. Product Name Effect Purity
  • HY-P9920A
    Ramucirumab (anti-VEGFR)
    		Antagonist 99.36%
    Ramucirumab (anti-VEGFR) is a human VEGFR-2 antagonist for the treatment of solid tumors. Ramucirumab (anti-VEGFR) is a recombinant human immunoglobulin G1 monoclonal antibody that binds to the extracellular binding domain of VEGFR-2 and prevents the binding of VEGFR ligands: VEGF-A, VEGF-C, and VEGF-D. Ramucirumab (anti-VEGFR) is also an angiogenesis inhibitor.